Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes Mellitus

NCT06427083 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Envlo Tablet
DRUG: Envolomet SR Tablet

Sponsor

Daewoong Pharmaceutical Co. LTD.